Priority Health, a nonprofit health plan, is teaming up with Ayble Health to provide digestive health support to its members, the companies announced on Wednesday. Grand Rapids, Michigan-based ...

On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test. The company, named Teal Health, was founded in 2020 and has raised $23 million.

Bringing a new drug to market is staggeringly inefficient: About 90% of new drugs fail in clinical trials, development times are 10-15 years, and the costs can run in excess of $2 billion dollars.

Finding a caregiver who meets your care needs and schedule requires planning and the right tools. Flexible caregiving is key for those with changing routines, shift work or evolving health needs.

Representative clinical studies are important as diseases and medicines can affect people differently depending on their age, sex, and race and ethnicity. According to the Food and Drug ...

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both ...

A rare type of ovarian cancer that grows slowly and responds poorly to chemotherapy now has its first FDA-approved treatment, a combination drug developed by Verastem Oncology to address a pathway ...

Withings Health Solutions and Babyscripts announced a partnership Thursday that aims to address hypertensive disorders of pregnancy, which are among the leading causes of maternal mortality.

Innovative marketing practices are the goal of every marketer; however, sometimes, it’s essential to consider not what new marketing tactic will be influential but how you can leverage existing ...

Medicaid was meant to be the solution. Then came the Affordable Care Act. But while the uninsured rate in America has reached historic lows, the financial burden on patients continues to rise.

Many drugs available and in development work by targeting proteins, an approach that comes with limitations. For one, proteins are not the root cause of disease, said Samir Ounzain, co-founder and ...